In the wake of President Javier Milei's peremptory abrogation of Argentina's Dirección de Asistencia Directa por Situaciones Especiales (DADSE) – the federal agency responsible for dispensing costly pharmaceuticals to cancer sufferers – a clandestine Facebook nexus has burgeoned, facilitating the surreptitious transfer of surplus medications between patient advocates and those in extremis; these draconian austerity measures, characterised by a near-halving of the healthcare budget, mass redundancies within the Ministry of Health, and the suspension of vital oncological screening and prophylactic immunisation programmes, evince a stark paradigm shift in Argentine healthcare provision, precipitating exorbitant price escalations in prescription pharmaceuticals and private health insurance (250% and 118% respectively), attenuating pensioner medical entitlements, and inexorably steering the nation towards a privatised, U.S.-style healthcare architecture – a context exacerbated by staffing decimation impeding immunisation strategising and epidemiological data collation, coinciding with a recrudescence of measles, the first such outbreak in decades, and a concomitant surge in sexually transmitted infections, including a 20% increment in HIV diagnoses and a 50% escalation in syphilis incidence; tragically, upwards of sixty oncology patients have reportedly succumbed following the DADSE programme's suspension, with in excess of 1,500 individuals languishing, deprived of essential pharmacological intervention.